These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18579238)

  • 1. Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: effects on proinflammatory cytokines and acute phase protein levels.
    Tousoulis D; Drolias A; Antoniades C; Vasiliadou C; Marinou K; Latsios G; Stefanadi E; Gounari P; Siasos G; Papageorgiou N; Trikas A; Stefanadis C
    Int J Cardiol; 2009 May; 134(2):238-43. PubMed ID: 18579238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression.
    Tousoulis D; Antoniades C; Drolias A; Stefanadi E; Marinou K; Vasiliadou C; Tsioufis C; Toutouzas K; Latsios G; Stefanadis C
    J Card Fail; 2008 Aug; 14(6):456-64. PubMed ID: 18672192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
    Machado M; Iskedjian M; Ruiz I; Einarson TR
    Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used.
    Fosbøl EL; Gislason GH; Poulsen HE; Hansen ML; Folke F; Schramm TK; Olesen JB; Bretler DM; Abildstrøm SZ; Sørensen R; Hvelplund A; Køber L; Torp-Pedersen C
    Circ Heart Fail; 2009 Nov; 2(6):582-90. PubMed ID: 19919983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Montgomery SA; Judge R
    Acta Psychiatr Scand Suppl; 2000; 403():9-16. PubMed ID: 11019930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder.
    Hou R; Ye G; Liu Y; Chen X; Pan M; Zhu F; Fu J; Fu T; Liu Q; Gao Z; Baldwin DS; Tang Z
    Brain Behav Immun; 2019 Oct; 81():105-110. PubMed ID: 31163212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia.
    McManus P; Mant A; Mitchell P; Dudley J
    Aust N Z J Psychiatry; 2004 Jun; 38(6):450-4. PubMed ID: 15209838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antidepressant medications: are there differences in psychiatric visits among patient treatments in the Veterans Administration?
    Hamed A; Lee A; Ren XS; Miller DR; Cunningham F; Zhang H; Kazis LE
    Med Care; 2004 Jun; 42(6):551-9. PubMed ID: 15167323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis.
    Undurraga J; Baldessarini RJ
    J Psychopharmacol; 2017 Sep; 31(9):1184-1189. PubMed ID: 28633600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.
    Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):722-6. PubMed ID: 19332097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
    von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
    J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.
    Lundberg J; Tiger M; Landén M; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1167-72. PubMed ID: 22243688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
    Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
    Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.